Letters to the Editor

The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia

Department of Gynecology, Wuhan University Renmin Hospital, Wuhan, Hubei, P. R. China;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA;
Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA;
Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA;
Department of Anatomy and Embryology, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei, P. R. China;
Department of Gynecology, Wuhan University Renmin Hospital, Wuhan, Hubei, P. R. China;
Department of Pharmacology & Experimental Therapeutics, Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA
Haematologica Early view Aug 13, 2020 https://doi.org/10.3324/haematol.2020.246918